231 related articles for article (PubMed ID: 18848843)
1. Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications.
Antonioli L; Fornai M; Colucci R; Ghisu N; Tuccori M; Del Tacca M; Blandizzi C
Pharmacol Ther; 2008 Dec; 120(3):233-53. PubMed ID: 18848843
[TBL] [Abstract][Full Text] [Related]
2. Enteric alpha-2 adrenoceptors: pathophysiological implications in functional and inflammatory bowel disorders.
Blandizzi C
Neurochem Int; 2007 Oct; 51(5):282-8. PubMed ID: 17618014
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions.
Fornai M; Antonioli L; Colucci R; Bernardini N; Ghisu N; Tuccori M; De Giorgio R; Del Tacca M; Blandizzi C
Pharmacol Ther; 2010 Jan; 125(1):62-78. PubMed ID: 19808045
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases.
Antonioli L; Fornai M; Colucci R; Ghisu N; Tuccori M; Del Tacca M; Blandizzi C
Inflamm Bowel Dis; 2008 Apr; 14(4):566-74. PubMed ID: 18022872
[TBL] [Abstract][Full Text] [Related]
5. Neuroimmune interaction in the gut: from bench to bedside.
Boeckxstaens GE
Verh K Acad Geneeskd Belg; 2006; 68(5-6):329-55. PubMed ID: 17313093
[TBL] [Abstract][Full Text] [Related]
6. 5-HT system in the gut: roles in the regulation of visceral sensitivity and motor functions.
Grundy D
Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():63-7. PubMed ID: 18924445
[TBL] [Abstract][Full Text] [Related]
7. Purinergic receptors in gastrointestinal inflammation.
Kolachala VL; Bajaj R; Chalasani M; Sitaraman SV
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G401-10. PubMed ID: 18063703
[TBL] [Abstract][Full Text] [Related]
8. Neuro-glial crosstalk in inflammatory bowel disease.
Neunlist M; Van Landeghem L; Bourreille A; Savidge T
J Intern Med; 2008 Jun; 263(6):577-83. PubMed ID: 18479256
[TBL] [Abstract][Full Text] [Related]
9. Disorders of interstitial cells of Cajal.
Burns AJ
J Pediatr Gastroenterol Nutr; 2007 Dec; 45 Suppl 2():S103-6. PubMed ID: 18185068
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory properties of substance P: the gastrointestinal system as a model.
Koon HW; Pothoulakis C
Ann N Y Acad Sci; 2006 Nov; 1088():23-40. PubMed ID: 17192554
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids and gastrointestinal motility: animal and human studies.
Aviello G; Romano B; Izzo AA
Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():81-93. PubMed ID: 18924447
[TBL] [Abstract][Full Text] [Related]
12. The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications.
Antonioli L; Colucci R; Pellegrini C; Giustarini G; Tuccori M; Blandizzi C; Fornai M
Pharmacol Ther; 2013 Aug; 139(2):157-88. PubMed ID: 23588157
[TBL] [Abstract][Full Text] [Related]
13. The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome.
Storr MA; Yüce B; Andrews CN; Sharkey KA
Neurogastroenterol Motil; 2008 Aug; 20(8):857-68. PubMed ID: 18710476
[TBL] [Abstract][Full Text] [Related]
14. Modulation of glial cell functions by adenosine receptors.
Daré E; Schulte G; Karovic O; Hammarberg C; Fredholm BB
Physiol Behav; 2007 Sep; 92(1-2):15-20. PubMed ID: 17574632
[TBL] [Abstract][Full Text] [Related]
15. Adenosine receptors and inflammation.
Blackburn MR; Vance CO; Morschl E; Wilson CN
Handb Exp Pharmacol; 2009; (193):215-69. PubMed ID: 19639284
[TBL] [Abstract][Full Text] [Related]
16. Purines and sensory nerves.
Burnstock G
Handb Exp Pharmacol; 2009; (194):333-92. PubMed ID: 19655112
[TBL] [Abstract][Full Text] [Related]
17. Review article: molecular, pathological and therapeutic features of human enteric neuropathies.
Di Nardo G; Blandizzi C; Volta U; Colucci R; Stanghellini V; Barbara G; Del Tacca M; Tonini M; Corinaldesi R; De Giorgio R
Aliment Pharmacol Ther; 2008 Jul; 28(1):25-42. PubMed ID: 18410560
[TBL] [Abstract][Full Text] [Related]
18. Enteric neuroplasticity evoked by inflammation.
Vasina V; Barbara G; Talamonti L; Stanghellini V; Corinaldesi R; Tonini M; De Ponti F; De Giorgio R
Auton Neurosci; 2006 Jun; 126-127():264-72. PubMed ID: 16624634
[TBL] [Abstract][Full Text] [Related]
19. The journey to establish purinergic signalling in the gut.
Burnstock G
Neurogastroenterol Motil; 2008 May; 20 Suppl 1():8-19. PubMed ID: 18402638
[TBL] [Abstract][Full Text] [Related]
20. Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease - clinical relevance and pathophysiological mechanisms.
De Schepper HU; De Man JG; Moreels TG; Pelckmans PA; De Winter BY
Aliment Pharmacol Ther; 2008 Apr; 27(8):621-37. PubMed ID: 18221407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
